CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation Outcomes of procedural complications in transfemoral transcatheter aortic valve replacement ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association Streamlined reverse wire technique for the treatment of complex bifurcated lesions Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience Superficial Calcium Fracture After PCI as Assessed by OCT Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromiummetallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial Sotatercept for the Treatment of Pulmonary Arterial Hypertension Long-Term Clinical Outcomes and Optimal Stent Strategy in Left Main Coronary Bifurcation Stenting Restricted access Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial
|<<... 137 138 139 140 141 142 143 ...>>|

Original ResearchJan 27, 2021.

JOURNAL：JACC: Cardiovascular Interventions Article Link

Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DES

KH Chau , AJ Kirtane , RM Easterwood et al. Keywords: platelet aggregate; ACS; stent thrombosis

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top